Hypercalcemia
Endocrine
Hypercalcemia is treated with 2 medications in our database, including CALCIUM GLUCONATE, Pamidronate Disodium. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Novartis. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Hypercalcemia treatment below.
What help exists for Hypercalcemia
15
drugs indexed
8
with copay cards
8
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Hypercalcemia
15 totalXTRENBO
Denosumab-qbde
Sensipar
cinacalcet hydrochloride · Amgen
Calcium Gluconate
Calcium Gluconate · Fresenius Kabi
Miacalcin
calcitonin salmon · Mylan
🎟💙CINACALCET
Cinacalcet · Amgen
Osenvelt
denosumab-bmwo
🎟💙Bilprevda
Denosumab · Janssen Biotech, Inc.
🎟💙XGEVA
denosumab · Amgen
🎟💙Oziltus
denosumab-mobz
WYOST
denosumab · Sandoz
🎟💙Cinacalcet Hydrochloride
Cinacalcet Hydrochloride · Amgen
Zoledronic Acid
Zoledronic Acid
🎟💙Pamidronate Disodium
PAMIDRONATE DISODIUM
AUKELSO
Denosumab-kyqq
🎟💙BOMYNTRA
Denosumab · Alnylam Pharmaceuticals
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Hypercalcemia drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
Showing 10 of 20 PA rules for Hypercalcemia drugs. View individual drug pages for complete PA detail.